These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30132262)

  • 1. Effect of metformin on blood pressure in patients with hypertension: a randomized clinical trial.
    Júnior VC; Fuchs FD; Schaan BD; Moreira LB; Fuchs SC; Gus M
    Endocrine; 2019 Feb; 63(2):252-258. PubMed ID: 30132262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
    Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Naaf S; Zimmermann BF; Stehle P; Egert S
    Br J Nutr; 2015 Oct; 114(8):1263-77. PubMed ID: 26328470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients.
    Snorgaard O; Køber L; Carlsen J
    J Intern Med; 1997 Nov; 242(5):407-12. PubMed ID: 9408071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial.
    He H; Zhao Z; Chen J; Ni Y; Zhong J; Yan Z; Li Y; Liu D; Pletcher MJ; Zhu Z
    J Hypertens; 2012 Jul; 30(7):1430-9. PubMed ID: 22525206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.
    Uehara MH; Kohlmann NE; Zanella MT; Ferreira SR
    Diabetes Obes Metab; 2001 Oct; 3(5):319-25. PubMed ID: 11703421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of α-linolenic acid on 24-h ambulatory blood pressure in untreated high-normal and stage I hypertensive subjects.
    Pieters DJ; Zock PL; Fuchs D; Mensink RP
    Br J Nutr; 2019 Jan; 121(2):155-163. PubMed ID: 30392473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Liakos A; Lambadiari V; Bargiota A; Kitsios K; Avramidis I; Kotsa K; Gerou S; Boura P; Tentolouris N; Dimitriadis G; Tsapas A
    Diabetes Obes Metab; 2019 Mar; 21(3):517-524. PubMed ID: 30242948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Correlates of Ambulatory Blood Pressure Phenotypes at a Tertiary Care Hospital in Turkey.
    Erdogmus S; Kutlay S; Celebi ZK; Aydın T; Ors Sendogan D; Kumru G; Keven K; Nergizoglu G; Erturk S; Sengul S
    Kidney Blood Press Res; 2018; 43(3):690-700. PubMed ID: 29763911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure-lowering effect of simvastatin: a placebo-controlled randomized clinical trial with 24-h ambulatory blood pressure monitoring.
    Correa V; Fuchs FD; Moreira LB; Gerhardt M; Fuchs SC; Sloczinski CR; Monteggia RG; Gus M
    J Hum Hypertens; 2014 Jan; 28(1):62-7. PubMed ID: 23677131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
    Kumarathurai P; Anholm C; Fabricius-Bjerre A; Nielsen OW; Kristiansen O; Madsbad S; Haugaard SB; Sajadieh A
    J Hypertens; 2017 May; 35(5):1070-1078. PubMed ID: 28129251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.
    Kanaki AI; Sarafidis PA; Georgianos PI; Stafylas PC; Kanavos K; Tziolas IM; Lasaridis AN
    J Hum Hypertens; 2012 Oct; 26(10):577-84. PubMed ID: 21881597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
    Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis.
    Pfeifer M; Townsend RR; Davies MJ; Vijapurkar U; Ren J
    Cardiovasc Diabetol; 2017 Feb; 16(1):29. PubMed ID: 28241822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.